Gregor Habl

2.4k total citations
64 papers, 1.8k citations indexed

About

Gregor Habl is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, Gregor Habl has authored 64 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 19 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Radiation. Recurrent topics in Gregor Habl's work include Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (18 papers) and Advanced Radiotherapy Techniques (17 papers). Gregor Habl is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (18 papers) and Advanced Radiotherapy Techniques (17 papers). Gregor Habl collaborates with scholars based in Germany, United States and Switzerland. Gregor Habl's co-authors include Jürgen Debus, Stephanie E. Combs, Klaus Herfarth, Matthias Uhl, Florian Sterzing, Matthias Eiber, Kilian Schiller, Sonja Katayama, Tobias Maurer and Uwe Haberkorn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Pain.

In The Last Decade

Gregor Habl

63 papers receiving 1.8k citations

Peers

Countries citing papers authored by Gregor Habl

Since Specialization

Citations

This map shows the geographic impact of Gregor Habl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Habl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Habl more than expected).

Fields of papers citing papers by Gregor Habl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor Habl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Habl. The network helps show where Gregor Habl may publish in the future.

Co-authorship network of co-authors of Gregor Habl

This figure shows the co-authorship network connecting the top 25 collaborators of Gregor Habl. A scholar is included among the top collaborators of Gregor Habl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregor Habl. Gregor Habl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	<p>Whole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma – final results of the BRAIN-RT trial</p> 2019 ·Cancer Management and Research ·Henrik Hauswald, Denise Bernhardt, David Krug, Sonja Katayama, Gregor Habl, Justo Lorenzo Bermejo, Jürgen Debus, Florian Sterzing	9
2	68 Ga-PSMA-PET for Radiation Treatment Planning in Prostate Cancer Recurrences After Surgery: Individualized Medicine or New Standard in Salvage Treatment 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Gregor Habl, (unknown), Kilian Schiller, (unknown), Tobias Maurer, Matthias Eiber, Stephanie E. Combs	5
3	Craniospinal irradiation using helical tomotherapy for central nervous system tumors 2017 ·Journal of Radiation Research ·(unknown), Gregor Habl, Matthias Häfner, Sonja Katayama, Klaus Herfarth, Jürgen Debus, Florian Sterzing	24
4	Strahlentherapeutisches Management von Lymphfisteln 2017 ·Der Chirurg ·Daniel Habermehl, Gregor Habl, Hans‐Henning Eckstein, F. Meisner, Stephanie E. Combs	2
5	Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study—The IPI Trial 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Gregor Habl, Matthias Uhl, Sonja Katayama, Kerstin A. Kessel, Gencay Hatiboglu, Boris Hadaschik, Lutz Edler, Diana Tichy, M. Ellerbrock, Thomas Haberer, (unknown), Heinz-Peter Schlemmer, Jürgen Debus, Klaus Herfarth	49
6	Rationale of hyperthermia for radio(chemo)therapy and immune responses in patients with bladder cancer: Biological concepts, clinical data, interdisciplinary treatment decisions and biological tumour imaging 2016 ·International Journal of Hyperthermia ·Gabriele Multhoff, Gregor Habl, Stephanie E. Combs	17
7	Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients 2016 ·Radiology and Oncology ·Arndt‐Christian Müller, Johannes Mischinger, Theodor Klotz, Bernd Gagel, Gregor Habl, Gencay Hatiboglu, Michael Pinkawa	33
8	Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate - first results of the PLATIN 1 trial 2015 ·BMC Cancer ·Gregor Habl, Sonja Katayama, Matthias Uhl, Kerstin A. Kessel, Lutz Edler, Jürgen Debus, Klaus Herfarth, Florian Sterzing	8
9	Scanned ion beam therapy for prostate carcinoma 2015 ·Strahlentherapie und Onkologie ·Sebastian Hild, Christian Graeff, Antoni Ruciński, Klemens Zink, Gregor Habl, Marco Durante, Klaus Herfarth, Christoph Bert	10
10	68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Florian Sterzing, Clemens Kratochwil, (unknown), Sonja Katayama, Gregor Habl, Klaus Kopka, Ali Afshar‐Oromieh, Jürgen Debus, Uwe Haberkorn, Frederik L. Giesel	174
11	Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial 2014 ·BMC Cancer ·Karin Potthoff, Gregor Habl, Thomas Brückner, (unknown), Jessica C. Hassel, Dirk Jäger, (unknown), Jürgen Debus	2
12	PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer 2013 ·European Journal of Nuclear Medicine and Molecular Imaging ·Ali Afshar‐Oromieh, Uwe Haberkorn, Boris Hadaschik, Gregor Habl, Matthias Eder, Michael Eisenhut, Heinz-Peter Schlemmer, Matthias Roethke	60
13	Intraoperative electron radiation therapy (IOERT) in patients with locally recurrent renal cell carcinoma 2013 ·Radiation Oncology ·Gregor Habl, Matthias Uhl, Frank W. Hensley, Sascha Pahernik, Jürgen Debus, Falk Röder	12
14	Preclinical investigations towards the first spacer gel application in prostate cancer treatment during particle therapy at HIT 2013 ·Radiation Oncology ·Antoni Ruciński, Julia Bauer, Patrick Campbell, Stephan Brons, Daniel Unholtz, Gregor Habl, Klaus Herfarth, Jürgen Debus, Christoph Bert, Katia Parodi, Oliver Jäkel, Thomas Haberer	17
15	Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis 2012 ·BMC Cancer ·Falk Roeder, Carmen Timke, Matthias Uhl, Gregor Habl, Frank W. Hensley, Markus W. Buechler, R. Krempien, Peter E. Huber, Jürgen Debus, Jens Werner	27
16	A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma 2012 ·BMC Cancer ·Falk Roeder, Daniela Schulz–Ertner, Anna Nikoghosyan, Peter Huber, Lutz Edler, Gregor Habl, R. Krempien, Susanne Oertel, L. Saleh-Ebrahimi, Frank W. Hensley, Markus W. Buechler, Jürgen Debus, Moritz Koch, Juergen Weitz, Marc Bischof	64
17	CT-Myelography for High-Dose Irradiation of Spinal and Paraspinal Tumors with Helical Tomotherapy 2011 ·Strahlentherapie und Onkologie ·Matthias Uhl, Florian Sterzing, Gregor Habl, Kai Schubert, G. Sroka-Pérez, Jürgen Debus, Klaus Herfarth	11
18	Rotational IMRT techniques compared to fixed gantry IMRT and Tomotherapy: multi-institutional planning study for head-and-neck cases 2011 ·Radiation Oncology ·Tilo Wiezorek, (unknown), Dietmar Georg, (unknown), Irina Fotina, Gregor Habl, Matthias Kretschmer, G. Lutters, Henning Salz, Kai Schubert, Daniela Wagner, Thomas Wendt	76
19	Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol 2010 ·BMC Cancer ·Gregor Habl, Alexandra D Jensen, Karin Potthoff, Matthias Uhl, Holger Hof, Jacek Hajda, Christian Simon, Jürgen Debus, R. Krempien, Marc Münter	7
20	Increased d-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study 2009 ·Journal of Neural Transmission ·Gregor Habl, Mathias Zink, Georg Petroianu, Manfred Bauer, Neil Thomas, Martina von Wilmsdorff, Peter Falkai, Fritz A. Henn, Andrea Schmitt	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact